Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

From integrated genomics to tumor lineage dependency.

Levi A Garraway1, William R Sellers

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Levi_Garraway@dfci.harvard.edu

Cancer Research
|March 3, 2006
PubMed
Summary

Genomic data can reveal cancer vulnerabilities. Researchers found the transcription factor MITF is an amplified oncogene in melanoma, crucial for its malignant traits, offering potential therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in <i>BRAF</i>-Mutant Melanoma.

bioRxiv : the preprint server for biology·2026
Same author

Context-dependent synthetic lethality - an emerging precision therapeutic approach.

Nature reviews. Cancer·2026
Same author

Systematic cysteine scanning identifies a druggable pocket in oncogenic KRAS.

Cell chemical biology·2026
Same author

RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors.

Molecular cancer research : MCR·2025
Same author

CRISPR-Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP-Deleted Cancer.

Cancer research·2025
Same author

Smoking habit and long-term colorectal cancer incidence by exome-wide mutational and neoantigen loads: evidence based on the prospective cohort incident-tumour biobank method.

BMJ oncology·2025

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Genomic information from tumors holds promise for identifying therapeutic targets.
  • Translating genomic data into actionable cancer therapies remains a challenge.
  • Understanding cancer cell lineage dependence is key to effective treatment.

Purpose of the Study:

  • To identify critical regulators of tumor lineage and their link to genomic alterations.
  • To explore the role of amplified oncogenes in cancer cell malignant character.
  • To investigate the potential of integrated genomic analyses for therapeutic target discovery.

Main Methods:

  • Integrated analysis of high-resolution single nucleotide polymorphism (SNP) maps.
  • Utilized gene expression databases from the NCI60 cancer cell line collection.

Related Experiment Videos

  • Identified amplified oncogenes and their functional significance in melanoma.

    • Main Results:

    • The transcription factor Microphthalmia-associated Transcription Factor (MITF) was identified as an amplified oncogene in melanoma.
    • MITF was found to be critical for anchoring melanoma lineage dependence.
    • MITF plays a significant role in maintaining the malignant character of melanoma cells.

    Conclusions:

    • MITF is a key oncogene in melanoma, essential for its lineage and malignant phenotype.
    • Integrated genomic approaches combining SNP maps and gene expression data are valuable for cancer research.
    • This methodology may be applicable to other cancer types for identifying critical lineage regulators.